Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6E4K
|
||||
| Drug Name |
(S)-1-[4-(4-Chloro-benzo[b]thiophen-2-yl)-piperidin-1-yl]-3-(1H-indol-4-yloxy)-propan-2-ol
|
||||
| Synonyms |
CHEMBL57296
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H25ClN2O2S
|
||||
| Canonical SMILES |
O[C@H](COc1cccc2[nH]ccc12)CN3CCC(CC3)c4cc5c(Cl)cccc5s4
|
||||
| InChI |
InChI=1S/C24H25ClN2O2S/c25-20-3-1-6-23-19(20)13-24(30-23)16-8-11-27(12-9-16)14-17(28)15-29-22-5-2-4-21-18(22)7-10-26-21/h1-7,10,13,16-17,26,28H,8-9,11-12,14-15H2/t17-/m0/s1
|
||||
| InChIKey |
FUQRJICYKKZXOM-KRWDZBQOSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.